Send to

Choose Destination
Bioimpacts. 2019;9(1):65. doi: 10.15171/bi.2019.08. Epub 2019 Jan 12.

Correction: A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model.

Author information

Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, USA.
Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland; Department of Oncology, University Hospital of Lausanne, Lausanne, Switzerland.


[This corrects the article DOI: 10.15171/bi.2018.24.].

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center